Bile acid malabsorption Approximately 10-20% of people develop bile acid malabsorption after gallbladder removal, a condition where excess bile acids enter the colon, causing diarrhoea
Retrieved from Davies, M., Frch, L., Jeppesen, O
The shortages have caused the company to expand and build new production facilities to meet the demand for Saxenda and other GLP-1 products
Clinical Indications and Who May Benefit Based on the preclinical literature and emerging clinical use patterns, BPC-157 is most commonly applied in the following areas: Tendon, ligament, and muscle injuries (sprains, partial tears, chronic tendinopathy) Post-surgical tissue healing and recovery acceleration Inflammatory bowel conditions (Crohns, ulcerative colitis, leaky gut syndromes) NSAID-induced gastric damage notably, BPC-157 counteracts aspirin- and ibuprofen-driven mucosal injury Neuropathy and nerve regeneration protocols Systemic inflammation and autoimmune flares Recovery from alcohol-related liver and gut damage It is also increasingly used as a component in broader peptide therapy protocols alongside BPC-157s companion compounds
KaplanMeier survival and Cox regression analyses were further performed to assess the prognosis